EMA To Advise On Tweaking COVID-19 Vaccines Due To New Variants

 
• By Vibha Sharma

Concerns that new or future mutations of the novel coronavirus may reduce the protection offered by existing COVID-19 vaccines have prompted the European Medicines Agency to develop guidance to help vaccine manufacturers who are planning to alter to their products.

Doctor in the lab holding a tube of blood identified with the label Covid-19 New Strain. Laboratory Technician with a blood sample with a new variant of the Coronavirus
Coronavirus Variants Found in The UK, South Africa and Brazil Have Drawn Concern • Source: Shutterstock

More from Vaccines

More from Pink Sheet